GeneDx (WGS) announced Linda Genen as chief medical officer. She joins GeneDx from ProgenyHealth.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WGS:
- GeneDx price target raised to $170 from $160 at Canaccord
- GeneDx price target raised to $155 from $140 at Wells Fargo
- GeneDx price target raised to $200, named 2026 Top Pick at BTIG
- TSLA, META: Cathie Wood Dumps These Two Magnificent 7 Stocks, Doubles Down on Trade Desk (TTD) Instead
- WGS, WRD, IRDM: Cathie Wood Ramps Up Buying in GeneDx and WeRide, Trims Exposure in Iridium stock